
IBM Stock: Stable Dividend or Stagnant Investment?
The AI race has heated up significantly but returns on…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $273.9B | $301.5B | $344.6B | $80.9B | $95.3B | |
Gross Profit | $12.6B | $12.3B | $13.3B | $3.2B | $3.3B | |
Operating Income | $4.3B | $3.9B | $4.5B | $646M | $1.3B | |
EBITDA | $5.2B | $4.4B | $5B | $835M | $1.4B | |
Diluted EPS | $21.81 | $22.07 | $21.84 | $4.42 | $6.95 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $42.4B | $46.5B | $44.7B | $47.6B | $51.7B | |
Total Assets | $61.8B | $63.7B | $62.7B | $66.5B | $71.1B | |
Current Liabilities | $41.9B | $47.5B | $48B | $51.7B | $58.6B | |
Total Liabilities | $60.8B | $64.5B | $64.8B | $68.2B | $73.8B | |
Total Equity | $1B | -$787M | -$2.1B | -$1.7B | -$2.7B | |
Total Debt | $7.4B | $6.3B | $6.5B | $5.9B | $8B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $4.7B | $3.5B | $2.5B | $254M | -$2.4B | |
Cash From Investing | -$115M | -$739M | -$1.1B | -$180M | -$136M | |
Cash From Financing | -$5.2B | -$3.6B | -$2.1B | -$622M | $1.3B | |
Free Cash Flow | $4.2B | $2.9B | $1.6B | $100M | -$2.6B |
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
In the current month, MCK has received 10 Buy ratings 3 Hold ratings, and 0 Sell ratings. The MCK average analyst price target in the past 3 months is $666.71.
According to analysts, the consensus estimate is that McKesson share price will rise to $666.71 per share over the next 12 months.
Analysts are divided on their view about McKesson share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that McKesson is a Sell and believe this share price will drop from its current level to $550.00.
The price target for McKesson over the next 1-year time period is forecast to be $666.71 according to 13 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for McKesson is a Buy. 10 of 13 analysts rate the stock a Buy at this time.
You can purchase shares of McKesson via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase McKesson shares.
McKesson was last trading at $659.04 per share. This represents the most recent stock quote for McKesson. Yesterday, McKesson closed at $644.22 per share.
In order to purchase McKesson stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
The AI race has heated up significantly but returns on…
Trimble (NASDAQ:TRMB) is a hardware and software tech company that…
It seems like right now is a good time to…
Market Cap: $3.6T
P/E Ratio: 39x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.6T
P/E Ratio: 36x
Willdan Group [WLDN] is down 3.66% over the past day.
Pro-Dex [PDEX] is up 10.33% over the past day.
Samsara [IOT] is down 3.68% over the past day.